Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Canada House Wellness Group’s Licensed Cannabis Producer Abba Medix Receives First Sales License from Health Canada


Posted on: 23 Jul 18

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

TORONTO, July 23, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) is pleased to announce that its wholly owned subsidiary, Abba Medix Corp. (“Abba”), a licensed cannabis producer under the Access to Cannabis for Medical Purposes Regulations (the "ACMPR") has successfully completed its Health Canada pre-sales inspection and has received an amendment to its Producer’s Licence from Health Canada to include the sale and provision of marihuana seeds, effective July 20, 2018.  

To support this sales license Abba has secured an exclusive Canadian distribution agreement with a well-established UK seed producer and now has access to more than 800 cannabis strains.  More than 200 of these strains are immediately available for sale by Abba.

Chris Churchill-Smith, Canada House’s CEO, commented, “I would like to congratulate our incredible team at Abba Medix Corp. on the receipt of the Company’s first sales license as we continue executing on our strategic plan and driving shareholder value.  This is an important milestone for our Company and a reflection of the top-quality team we have at Abba.  As the industry continues to mature, we believe a major differentiator amongst industry peers will be the ability to understand and closely adhere to the regulatory environment in which we operate.  Our team has demonstrated yet again that we are at the top of our discipline in this regard and ready for continued success interacting with Health Canada.  This sales license, one of several we expect to obtain this year, and our exclusive distribution agreement will allow Abba to obtain one of the largest genetic libraries in the industry.  In addition to creating revenues through seed sales, this sales licence compliments Abba’s exclusive and recently announced Canadian licence of Medicine Man Technologies’ Intellectual Property as it will provide our Cultivation Max clients access to premium genetics bred to perform with our proven production methodologies.  I would also like to thank Health Canada, Canadian Food Inspection Agency, the UK Export Division and the UK Animal and Plant Health Agency for their cooperation and support in obtaining this sales licence.”

Licenced Producers that would like to purchase genetics can contact Abba at customerservice@abbamedix.com.

Canada House Wellness Group Inc.

Canada House is the parent company of Marijuana for Trauma Inc., Knalysis Technologies and Abba Medix Corp. The Company's goal is to become a marketplace leader through strategic partnerships, mergers, and acquisitions to create a fully integrated cannabis therapy company. For more information please visit http://www.canadahouse.ca or www.sedar.com.

For further information, please contact:

Boom Capital Markets
Steve Low
647-620-5101
steve@boomcapitalmarkets.com

Canada House Wellness Group Inc.
Chris Churchill-Smith
CEO
514-313-0102
chris.smith@canadahouse.ca

Cautionary Statement Regarding Forward Looking Information. Certain statements within this news release pertaining to the Company may constitute “forward looking statements”, within the meaning of applicable securities laws. Forward-looking statements may be identified by the use of terminology such as “believes,” “expects,” “anticipates,” “assumes,” “plans,” or other similar words. Such forward-looking statements involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law.

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

GlobeNewswire
globenewswire.com

Last updated on: 23/07/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.